TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,635 | -7.6% | 820 | 0.0% | 0.00% | – |
| Q2 2022 | $11,513 | -2.0% | 820 | 0.0% | 0.00% | – |
| Q1 2022 | $11,742 | +5.1% | 820 | 0.0% | 0.00% | – |
| Q4 2021 | $11,177 | -66.5% | 820 | -59.8% | 0.00% | -100.0% |
| Q3 2021 | $33,399 | -2.7% | 2,039 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $34,316 | -5.6% | 2,039 | +2.4% | 0.00% | -50.0% |
| Q1 2021 | $36,356 | +96.0% | 1,991 | +95.4% | 0.00% | +100.0% |
| Q4 2020 | $18,546 | -71.9% | 1,019 | -72.4% | 0.00% | -75.0% |
| Q3 2020 | $65,901 | +267.5% | 3,694 | +269.4% | 0.00% | +300.0% |
| Q2 2020 | $17,930 | +42.5% | 1,000 | +20.6% | 0.00% | 0.0% |
| Q1 2020 | $12,584 | -29.1% | 829 | -7.8% | 0.00% | 0.0% |
| Q4 2019 | $17,737 | +145.5% | 899 | +114.0% | 0.00% | 0.0% |
| Q3 2019 | $7,224 | +103.0% | 420 | +109.0% | 0.00% | – |
| Q2 2019 | $3,558 | +2.2% | 201 | +17.5% | 0.00% | – |
| Q1 2019 | $3,483 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |